Schizophrenia research grapples with trial design hurdles in hunt for new treatments
Placebo response in acute schizophrenia trials has been rising for decades. At the same time, the observed treatment benefit is…
All articles by Jam Bensilum
Jam Bensilum
Jam Bensilum is a healthcare and pharmaceutical reporter. She has a background in medical communications with extensive experience across both medical affairs and publications. She holds an MSc in Molecular Medicine from Imperial College London and has interests in oncology, infectious disease, biologics, mental health and women’s health.
-
-
Participant enrolment and retention key to clinical trial derisking
As the complexity of clinical trials continues to grow, enhancing patient centricity, improving site and contract research organisation (CRO) collaboration…
-
Implementing AI in workflows: One step at a time
Artificial Intelligence (AI) is increasingly framed as a transformative tool that can address inefficiencies across therapeutic research and development (R&D).…
-
EU’s Joint Clinical Assessment system still finding its footing
In April, Ipsen’s Ojemda (tovorafenib) secured European Commission (EC) approval for the treatment of relapsed or refractory paediatric low-grade glioma.…
-
OCT Europe 2026: tackling clinical trial complexities with innovation and partnerships
Regulatory changes, geopolitical pressures and technological advancements are among the factors currently driving new and evolving challenges within the clinical…
-
Calls for change as access to cell and gene therapies in the Netherlands falls short
The Netherlands is falling behind other European countries in providing access to advanced therapy medicinal products (ATMPs) according to Peter…
-
How new technologies could transform clinical trial execution
Clinical trials are facing new and evolving challenges as costs increase and approval timelines remain lengthy. Modernisation of processes and…
-
Precision medicine approaches needed in oncology to match evolving SoC
As the standard of care (SoC) for new drugs in oncology continues to improve, trials need to be designed with…
-
Can regulatory reform unearth LATAMs untapped potential for drug development?
Pivotal regulatory reform, digitalisation and improved regional cooperation are transforming countries such as Argentina, Brazil, Mexico, and other Latin America…
-
Utilising real-world data to overcome challenges in rare disease research
Innovative approaches like synthetic control arms based on real-world data may help overcome the unique challenges faced in clinical trials…